載入...
Safety concerns about intravenous iron therapy in patients with chronic kidney disease
Anaemia in chronic kidney disease (CKD) is managed primarily with erythropoiesis-stimulating agents (ESAs) and iron therapy. Following concerns around ESA therapy, intravenous (IV) iron is being administered more and more worldwide. However, it is still unclear whether this approach is safe at very...
Na minha lista:
| 發表在: | Clin Kidney J |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4792617/ https://ncbi.nlm.nih.gov/pubmed/26985378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfv142 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|